{
    "2018-03-20": [
        [
            {
                "time": "2018-03-20",
                "original_text": "明日最具投资机会六大牛股一览（3月20日）",
                "features": {
                    "keywords": [
                        "投资机会",
                        "牛股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-20",
                "original_text": "合作上海交大 布局生物制药",
                "features": {
                    "keywords": [
                        "合作",
                        "上海交大",
                        "生物制药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-20",
                "original_text": "[强烈推荐评级]凯莱英(002821)事件点评：生物药研发服务布局初步落地 公司四大战略规划稳步推进未来3年高增速可期",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "生物药",
                        "研发服务",
                        "战略规划",
                        "高增速"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-20",
                "original_text": "【天风Morning Call】晨会集萃20180320",
                "features": {
                    "keywords": [
                        "天风Morning Call",
                        "晨会集萃"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-20",
                "original_text": "凯莱英点评报告:校企共建联合实验室,进军大分子药物领域",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "校企共建",
                        "联合实验室",
                        "大分子药物"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-20",
                "original_text": "医药行业中国研发外包行业迎来高景气周期(系列二):基于12家CRO、CDMO企业的比较分析",
                "features": {
                    "keywords": [
                        "医药行业",
                        "研发外包",
                        "高景气周期",
                        "CRO",
                        "CDMO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}